I graduated with a PhD in chemistry from the University of Heidelberg, Germany in 1995. I spent a year as a Postdoc at Cornell University in Ithaca, NY, then worked as a medicinal chemist for GlaxoSmithKline in Cape Town, South Africa.
I joined Austin Health in 1998 as a radiochemist. Initially, I did a lot of carbon-11 work and established the procedure for the first C-11 PIB scan in Australia. I have extensive experience in performing first-in-human studies with neuroscience and oncology tracers labelled with C-11, F-18 and Zr-89. My main research interests are in synthesis automation, labelling of peptides ad antibodies as well as hypoxia.
Dr Sicong Tu is excited about helping motor neurone disease (MND) patients gain a much better idea of their disease progression: “The focus of our network is on bridging the gap between leading Aust
28 May 2025
A new national-scale molecular-imaging network that aims to improve cancer imaging, dementia diagnosis and treatment, and new radiopharmaceuticals was launched Saturday at the annual meeting for Austr
26 May 2025
Professor Michael Hofman appeared on 2GB Radio to talk about a recent major boost for cancer research at Peter MacCallum Cancer Centre.
25 February 2025
The Governor-General, Her Excellency the Honourable Sam Mostyn AC has announced the award of Australian Cancer Research Foundation’s (ACRF) 2024 grants at Government House in Canberra. The announcem
25 November 2024
Rebecca V Robertson, Noemi Meylakh, Lewis S Crawford, Fernando A Tinoco Mendoza, Paul M Macey, Vaughan G Macefield, Kevin A Keay, Luke A Henderson
Read Publication
Joseph J. Bartlett, Catherine E. Davey, Leigh A. Johnston, Jinming Duan
Read Publication